nano microneedle patch smgt-glp-1 smgt glp 1 GLP-1 Review Nano Micro Needle Plaster, SMGT-GLP-1

Tirzepatide, novel dual GIP/GLP-1 receptor agonist, is a new antihyperglycemic agent that was approved by the US Food and Drug Administration (United States) (FDA) in May 2022 that has demonstrated the highest HbA1C and weight reduction as a non-insulin agent

It is prescribed by doctors for adults who are grappling with obesity, having a body mass index (BMI) higher than 30, or those who are overweight, with a BMI higher than 27

Concurrent medications and medical conditions: Patients taking GLP-1 medications often have multiple comorbidities and take other medications that may affect respiratory function

They're not working against your biology